{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:05:21Z","timestamp":1791255921983,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2467,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/jto.0b013e318197f302","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T01:09:24Z","timestamp":1264554564000},"page":"404-408","source":"Crossref","is-referenced-by-count":11,"title":["Intrapleural Administration of Pemetrexed: A Pharmacokinetic Study in an Animal Model"],"prefix":"10.1016","volume":"4","author":[{"given":"Laurent","family":"Greillier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Monjanel-Mouterde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fraticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Devictor-Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bouvenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Coltel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Lamarche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Astoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e318197f302_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-5002(02)00180-0","article-title":"Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis","volume":"38","author":"Berghmans","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318197f302_bib2","first-page":"1116","article-title":"LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes","volume":"57","author":"Shih","year":"1997","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e318197f302_bib3","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318197f302_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s002800050992","article-title":"A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation","volume":"44","author":"Rinaldi","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1097\/JTO.0b013e318197f302_bib5","first-page":"605","article-title":"A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate","volume":"4","author":"McDonald","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e318197f302_bib6","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1200\/JCO.1995.13.11.2842","article-title":"Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation","volume":"13","author":"Rinaldi","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318197f302_bib7","first-page":"S18-40","article-title":"Antifolates in clinical development","volume":"24","author":"Takimoto","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1097\/JTO.0b013e318197f302_bib8","first-page":"171","article-title":"Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions","volume":"7","author":"Monjanel-Mouterde","year":"2000","journal-title":"Oncol Rep"},{"key":"10.1097\/JTO.0b013e318197f302_bib9","first-page":"4254","article-title":"Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II)","volume":"50","author":"Perez-Soler","year":"1990","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e318197f302_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1008203100410","article-title":"Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion","volume":"8","author":"Lerza","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e318197f302_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02897262","article-title":"Intrapleural etoposide for malignant effusion","volume":"26","author":"Holoye","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1097\/JTO.0b013e318197f302_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001813-199707000-00003","article-title":"A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions","volume":"8","author":"Perng","year":"1997","journal-title":"Anticancer Drugs"},{"key":"10.1097\/JTO.0b013e318197f302_bib13","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man","volume":"50","author":"Freireich","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1097\/JTO.0b013e318197f302_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/ejso.2000.0983","article-title":"Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model","volume":"26","author":"Pestieau","year":"2000","journal-title":"Eur J Surg Oncol"},{"key":"10.1097\/JTO.0b013e318197f302_bib15","first-page":"1055","article-title":"Comparison of the iv and ip routes of administration of cisplatin in dogs","volume":"65","author":"Pretorius","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1097\/JTO.0b013e318197f302_bib16","first-page":"545","article-title":"Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy","volume":"1","author":"Niyikiza","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0b013e318197f302_bib17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/cncr.22466","article-title":"Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses","volume":"109","author":"Elit","year":"2007","journal-title":"Cancer"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415309953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415309953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T13:55:32Z","timestamp":1544709332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415309953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1556086415309953"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e318197f302","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}